Background Prior research indicates rising methamphetamine use and harms in the US,
potentially related to increases in methamphetamine injection. To date, research on trends …

Background Medications such as buprenorphine are considered the gold standard for the
treatment of opioid use disorders. This study aimed to determine whether less restrictive …

Background The dominant focus of North America's current overdose crisis has been
opioids, resulting in considerable research and harm reduction efforts to address opioid …

Objective Higher opioid overdoses and drug use have reportedly occurred during the
COVID-19 pandemic. We provide evidence on how emergency department (ED) visits for …

Background and Objectives Opioid‐related overdose deaths in North America have
increased drastically, partially due to the increased prevalence of illicitly manufactured …

Rates of stimulant use, including misuse of prescription stimulants and use of cocaine and
methamphetamine, are rising rapidly among adolescents and young adults (“youth”) …

Background Rising rates of fentanyl-and polydrug-involved drug overdose deaths have
prompted inquiry into the role of drug supply in fatal overdose outcomes in the United States …

The number of drug overdoses and deaths has increased significantly over the past decade
and co-use of opioids and stimulants is associated with greater likelihood of overdose and …

Background The Covid-19 pandemic and its accompanying public-health orders (PHOs)
have led to (potentially countervailing) changes in various risk factors for overdose. To …

Opioid overdose is a leading cause of death in the United States. The only treatment
available currently is the competitive antagonist, naloxone (Narcan®). Although naloxone is …